Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00102011 · ClinicalTrials.gov registry record · Phase 3
Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer
A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 4,952
- Enrollment target
NCT00102011: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00102011 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 4,952 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00102011, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 4,952 participants
- Enrollment target
Study Summary
RATIONALE: Screening tests, such as colonoscopy and fecal occult blood test, may help doctors find tumor cells early and plan better treatment for colorectal cancer. PURPOSE: This randomized phase III trial is studying colonoscopy to see how well it works compared to fecal occult blood test in screening healthy participants for colorectal cancer.
Interventions
- PROCEDURE standard follow-up care
- PROCEDURE fecal occult blood test
- PROCEDURE screening colonoscopy
- PROCEDURE annual screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,952 participants |
| Start Date | 2000-05-25 |
| Est. Completion | 2026-03-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00102011
The ClinicalTrials.gov registry entry for NCT00102011 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 4,952 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which standard follow-up care is the first listed.
NCT00102011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00102011 about?
NCT00102011 is a clinical study titled "Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer". RATIONALE: Screening tests, such as colonoscopy and fecal occult blood test, may help doctors find tumor cells early and plan better treatment for colorectal cancer. PURPOSE: This randomized phase III trial is studying colonoscopy to see how well it works compared to fecal occult blood test in scre...
What is the current status of trial NCT00102011?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 4,952 participants. The study started on 2000-05-25. Estimated completion is 2026-03-05.
What interventions are being tested in trial NCT00102011?
The interventions under investigation include: standard follow-up care (PROCEDURE), fecal occult blood test (PROCEDURE), screening colonoscopy (PROCEDURE), annual screening (PROCEDURE).
Who is sponsoring clinical trial NCT00102011?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.